Co-Diagnostics Intends to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
Co-Diagnostics has withdrawn its 510(k) application for its Co-Dx PCR COVID-19 Test in favor of submitting an enhanced version.
Read MorePosted by Chris Wolski | Feb 21, 2025 | Covid 19 |
Co-Diagnostics has withdrawn its 510(k) application for its Co-Dx PCR COVID-19 Test in favor of submitting an enhanced version.
Read MorePosted by Chris Wolski | Feb 18, 2025 | Covid 19 |
Hologic, Inc. has received FDA 510(k) clearance for its Aptima SARS-CoV-2 assay, initially authorized for emergency use in 2020.
Read MorePosted by Chris Wolski | Feb 13, 2025 | Molecular Diagnostics |
Thermo Fisher Scientific has received FDA 510(k) clearance for its Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, a real-time PCR multiplex test.
Read MorePosted by Chris Wolski | Feb 11, 2025 | POC Instruments |
Researchers developed a portable, at-home, wireless device that simultaneously detects SARS-CoV-2 and vitamin C levels.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Covid 19 |
Researchers identified key SARS-CoV-2 mutations that increased the virus’ ability to spread via a novel genomic surveillance model.
Read More